Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial - Concepedia

Concepedia

Publication | Open Access

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

DOI Full Paper Access

94

Citations

12

References

2018

Year

Luca Malorni, Giuseppe Curigliano, Alessandro Marco Minisini, Saverio Cinieri, Carlo Tondini, Koenraad D’Hollander, Grazia Arpino, Antônio Bernardo, Angelo Martignetti, Carmen Criscitiello,

Annals of Oncology

Abstract

NCT02549430.

References

	Year	Citations

Page 1